Entering text into the input field will update the search result below

Pulmonx Corporation (LUNG) CEO Glendon French on Q4 2020 Results - Earnings Call Transcript

Mar. 02, 2021 9:00 PM ETPulmonx Corporation (LUNG)
SA Transcripts profile picture
SA Transcripts

Pulmonx Corporation (NASDAQ:LUNG) Q4 2020 Earnings Conference Call March 2, 2021 4:30 PM ET

Company Participants

Brian Johnston - Investor Relations

Glendon French - President & Chief Executive Officer

Derrick Sung - Chief Financial Officer

Conference Call Participants

Robert Hopkins - Bank of America

Frederick Wise - Stifel

Lawrence Biegelsen - Wells Fargo Securities

William Plovanic - Canaccord Genuity


Good afternoon, and welcome to Pulmonx Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of this call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Brian Johnston from the Gilmartin Group for a few introductory comments. Go ahead.

Brian Johnston

Thanks, Operator. Good afternoon and thank you all for participating in today's call. Joining me from Pulmonx are Glenn French, President and Chief Executive Officer; and Derrick Sung, Chief Financial Officer. Earlier today, Pulmonx released financial results for the quarter and year ended December 31, 2020. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of Federal Securities Laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward looking statements, including without limitation, those relating to our operating trends and future financial performance, the impact of COVID-19 on our business and prospects for recovery, expense management, expectations for hiring, growth in our organization, market opportunity, guidance for revenue, gross margin and operating expenses, commercial expansion and the product pipeline development are based on

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.